Loss of CD4+ T cells by HIV infection, or diminished antigen-specific CD4+ T cell activity by tumor or virus-induced downregulation of MHC class II impairs induction, expansion, and efficacy of CTL responses capable of viral or tumor clearance, and means to rectify this are needed for both HIV and cancer. This evidence concerns the gene CD4 and cancer.